Werewolf Therapeutics, Inc.

US$1.01As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:HOWLHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (39.42%)
Div yield —
ROE (119.86%)
Biotechnology
Beta (5Y) 0.55
PE TTM —
TSR TTM (22.90%)
Mkt cap US$49.09M
ROIC (33.68%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.07
6.30%
34.02%
Hold 10|8|11|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
(0.07%)
10.66%
3.90%
15.35%
Revenue$M
2.929
2.930
3.024
3.151
4.00%
1.45%
6.73%
11.12%
Peers (US$49.09M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.657
(0.131)
(0.141)
EBIT/Intx
0.744
0.069
0.065
Own earn%
(101.10)
(51.92)
(64.41)
Sh yield%
41.43
58.23
52.25
Owners
Insiders/Inst%
0.95
44.46
Short interest%
3.90
SBC / revenue%
4.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
6–12
$1 testx
—
Incr. ROIC%
4